Floatz logo

FILGRASTIM

Conditioning

First Affiliated Hospital Xi'an Jiaotong Universityprotein_peptidePhase 2/3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Conditioning cohort.

Asset / SponsorPhaseRating
Evomela
First Affiliated Hospital of Zhejiang University
Phase 3BB
Fludarabine
First Affiliated Hospital of Zhejiang University
Phase 3BB
Cyclophosphamide
First Affiliated Hospital Xi'an Jiaotong University
Phase 2/3B
Busulphan
First Affiliated Hospital Xi'an Jiaotong University
Phase 2/3B
Venetoclax
First Affiliated Hospital of Zhejiang University
Phase 3B

View all 15 →

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →